Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples